支付意愿在测量皮肤疾病负担中的意义与应用

doi:10.3760/cma.j.issn.0412-4030.2019.04.015

中华皮肤科杂志 ›› 2019, Vol. 52 ›› Issue (4): 286-289.doi: 10.3760/cma.j.issn.0412-4030.2019.04.015

支付意愿在测量皮肤疾病负担中的意义与应用

肖易¹ 陈丽萍¹ 敬丹榕¹ 粟娟¹ 李濛² 沈敏学¹ 陈翔¹

¹中南大学湘雅医院皮肤科皮肤健康与疾病湖南省工程研究中心皮肤肿瘤与银屑病湖南省重点实验室，长沙 410000； ² University of Southern California Schaeffer Center for Health Policy and Economics，Los Angeles 90089，USA

收稿日期:2018-12-03 修回日期:2019-02-19 出版日期:2019-04-15 发布日期:2019-04-01
通讯作者: 陈翔；沈敏学 E-mail:chenxiangck@126.com; snowflake0921@163.com
基金资助:
国家重点研发计划精准医学项目（2016YFC0900802）

Application and significance of willingness-to-pay in measuring the burden of skin diseases

Xiao Yi¹, Chen Liping¹, Jing Danrong¹, Su Juan¹, Li Meng², Shen Minxue¹, Chen Xiang¹

¹Department of Dermatology, Xiangya Hospital, Central South University, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Changsha 410000, China; ²University of Southern California Schaeffer Center for Health Policy and Economics , Los Angeles 90089, USA

Received:2018-12-03 Revised:2019-02-19 Online:2019-04-15 Published:2019-04-01
Contact: Chen Xiang; Shen Minxue E-mail:chenxiangck@126.com; snowflake0921@163.com
Supported by:
National Precision Medicine Project of China（2016YFC0900802）

摘要/Abstract

摘要： 【摘要】 “生物-心理-社会”的新型医学模式要求我们综合评价疾病的状态和负担，健康相关生活质量在疾病负担的测算中是一个重要的考量指标。传统的健康相关生活质量的评价方法有基于间距的测量方法和基于偏好相关的测量方法，后者包括健康效用和支付意愿等。本文系统介绍支付意愿，回顾其在皮肤疾病中的应用。目前关于皮肤疾病的支付意愿研究总体仍存在数量少、涉及皮肤病种类少、样本量小等问题。在对于皮肤疾病的卫生经济学评价的实际应用中，支付意愿作为治疗增益的近似指标，较以健康效用为指标的效用增益更具实用价值。随着卫生经济学研究在皮肤疾病中逐渐起步，皮肤疾病支付意愿等评价方法的重视程度增高，有望开展基于更大规模人群、涉及更多病种的皮肤疾病卫生经济学相关研究。

关键词: 皮肤疾病, 患病代价, 生活质量, 支付意愿, 健康效用

Abstract: 【Abstract】 According to the new biopsychosocial medical model, status and burden of diseases should be evaluated comprehensively, and health-related quality of life can be an important measurement index of the burden of diseases. Conventional assessment methods for health-related quality of life include interval-based assessment methods and preference-based assessment methods （health utilities and willingness-to-pay）. This review introduces willingness-to-pay, and summarizes its applications in skin diseases. However, at present, only a small quantity of small-scale studies are available on willingness-to-pay, with only a few kinds of skin diseases involved. In the application of health-economic assessment of skin diseases, willingness-to-pay can serve as an approximate index of benefit gains, and be more valuable in practice than health utilities （the index of utility gains）. With the increase in health-economic researches on skin diseases, more attention is paid to the willingness-to-pay for skin diseases and other health-economic assessment methods, and large-scale health-economic assessment-related researches are expected to be conducted on more kinds of skin diseases.

Key words: Skin diseases, Cost of illness, Quality of life, Willingness?to?pay, Health utilities

肖易陈丽萍敬丹榕粟娟李濛沈敏学陈翔. 支付意愿在测量皮肤疾病负担中的意义与应用[J]. 中华皮肤科杂志, 2019, 52(4): 286-289.

Xiao Yi, Chen Liping, Jing Danrong, Su Juan, Li Meng, Shen Minxue, Chen Xiang. Application and significance of willingness-to-pay in measuring the burden of skin diseases[J]. Chinese Journal of Dermatology, 2019, 52(4): 286-289.

参考文献 19

［1］	Engel GL. The need for a new medical model: a challenge for biomedicine［J］. Science, 1977,196（4286）:129⁃136.
［2］	Kini SP, DeLong LK. Overview of health status quality⁃of⁃life measures［J］. Dermatol Clin, 2012,30（2）:209⁃221, xiii. doi: 10. 1016/j.det.2011.11.007.
［3］	Olsen JA, Smith RD. Theory versus practice: a review of
	′willingness⁃to⁃pay′ in health and health care［J］. Health Econ, 2001,10（1）:39⁃52.
［4］	Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes［M］. 4th ed. New York: Oxford University Press, 2015:355⁃356. doi: 10.1136/jech.41.4.355⁃a.
［5］	Stoniute J, Mott DJ, Shen J. Challenges in valuing temporary health states for economic evaluation: a review of empirical applications of the chained time trade⁃off method［J］. Value Health, 2018,21（5）:605⁃611. doi: 10.1016/j.jval.2017.08.3015.
［6］	Seidler AM, Bayoumi AM, Goldstein MK, et al. Willingness to pay in dermatology: assessment of the burden of skin diseases［J］. J Invest Dermatol, 2012,132（7）:1785⁃1790. doi: 10.1038/jid. 2012.50.
［7］	Hu SW, Holt EW, Husni ME, et al. Willingness⁃to⁃pay stated preferences for 8 health⁃related quality⁃of⁃life domains in psoriatic arthritis: a pilot study［J］. Semin Arthritis Rheum, 2010,39（5）:384⁃397. doi: 10.1016/j.semarthrit.2008.10.005.
［8］	Dobrev HP, Atanasov NG, Dimitrova DD. Implementation of instrument based on eight health related quality of life domains for measuring of willingness to pay for psoriasis treatment［J］. Folia Med （Plovdiv）, 2017,59（3）:326⁃335. doi: 10.1515/folmed⁃2017⁃0041.
［9］	Ko WC, Tsai TF, Tang CH. Health state utility, willingness to pay, and quality of life among Taiwanese patients with psoriasis［J］. Dermatologica Sinica, 2016,34（4）:185⁃191. doi: 10.1016/j.dsi. 2016.05.004.
［10］	Lundberg L, Johannesson M, Silverdahl M, et al. Quality of life, health⁃state utilities and willingness to pay in patients with psoriasis and atopic eczema［J］. Br J Dermatol, 1999,141（6）:1067⁃1075.
［11］	Beikert FC, Langenbruch AK, Radtke MA, et al. Willingness to pay and quality of life in patients with atopic dermatitis［J］. Arch Dermatol Res, 2014,306（3）:279⁃286. doi: 10.1007/s00403⁃013⁃1402⁃1.
［12］	Krammer R, Heinzerling L. Therapy preferences in melanoma treatment⁃⁃willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls［J/OL］. PLoS One, 2014,9（11）:e111237. ［2019⁃03⁃10］. https://journals. plos.org/plosone/article?id=10.1371/journal.pone.0111237. doi: 10.1371/journal.pone.0111237.
［13］	Augustin M, Blome C, Forschner A, et al. Willingness to pay for a cure of low⁃risk melanoma patients in Germany［J/OL］. PLoS One, 2018,13（5）:e0197780. ［2019⁃03⁃10］. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967822/. doi: 10.1371/journal.pone.0197780.
［14］	Radtke MA, Schäfer I, Gajur A, et al. Willingness⁃to⁃pay and quality of life in patients with vitiligo［J］. Br J Dermatol, 2009,161（1）:134⁃139. doi: 10.1111/j.1365⁃2133.2009.09091.x.
［15］	Beikert FC, Langenbruch AK, Radtke MA, et al. Willingness to pay and quality of life in patients with rosacea［J］. J Eur Acad Dermatol Venereol, 2013,27（6）:734⁃738. doi: 10.1111/j.1468⁃3083.2012.04549.x.
［16］	Leeyaphan C, Wanitphakdeedecha R, Manuskiatti W, et al. Measuring melasma patients′ quality of life using willingness to pay and time trade⁃off methods in Thai population［J］. BMC Dermatol, 2011,11:16. doi: 10.1186/1471⁃5945⁃11⁃16.
［17］	Schiffner R, Brunnberg S, Hohenleutner U, et al. Willingness to pay and time trade⁃off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains［J］. Br J Dermatol, 2002,146（3）:440⁃447.
［18］	Cham PM, Chen SC, Grill JP, et al. Reliability of self⁃reported willingness⁃to⁃pay and annual income in patients treated for toenail onychomycosis［J］. Br J Dermatol, 2007,156（5）:922⁃928. doi: 10.1111/j.1365⁃2133.2006.07740.x.
［19］	Tamiru A, Tsegay G, Wubie M, et al. Podoconiosis patients′ willingness to pay for treatment services in Northwest Ethiopia: potential for cost recovery［J］. BMC Public Health, 2014,14:259. doi: 10.1186/1471⁃2458⁃14⁃259.

[1]	李遇梅张怡萱刘莉萍. 诱导性多功能干细胞在皮肤科研究与应用的进展[J]. 中华皮肤科杂志, 2019, 52(7): 445-449.
[2]	张少龙常毓倩林兴潇苏馨坚哲李春英. 遮盖疗法在白癜风治疗中的应用[J]. 中华皮肤科杂志, 2019, 52(4): 283-285.
[3]	汤顺利方红. 雄激素性秃发的发病机制[J]. 中华皮肤科杂志, 2019, 52(3): 208-210.
[4]	钱玥彤刘佳玮刘薇马东来. 放射治疗相关性皮肤病[J]. 中华皮肤科杂志, 2019, 52(2): 145-148.
[5]	钱玥彤马东来. Janus酪氨酸激酶抑制剂在皮肤科的应用[J]. 中华皮肤科杂志, 2018, 51(9): 704-707.
[6]	林雅燕程波陈丽红刘茁纪明开. 四例皮肤非结核分枝杆菌感染临床分析[J]. 中华皮肤科杂志, 2018, 51(6): 463-464.
[7]	李明静曹经江陈宏翔. 光动力治疗中疼痛管理研究进展[J]. 中华皮肤科杂志, 2016, 49(9): 676-679.
[8]	郭丙辰韩娜娜周江峰. 改良连续皮内缝合在皮肤外科手术中的临床应用[J]. 中华皮肤科杂志, 2014, 47(12): 889-891.
[9]	杨海平顾恒. 银屑病对生活质量的影响及其对策[J]. 中华皮肤科杂志, 2012, 45(8): 603-606.
[10]	刘丹丹赫晓燕. 微小RNA在皮肤疾病中的调控作用研究进展[J]. 中华皮肤科杂志, 2010, 43(12): 892-894.
[11]	樊应俊冒长峙. 肾源性纤维组织增生性皮肤病一例[J]. 中华皮肤科杂志, 2009, 42(11): 793-794.
[12]	尹逊国,何黎,万屏. 皮肤病住院患者31例死亡回顾性分析[J]. 中华皮肤科杂志, 2008, 41(11): 755-.
[13]	崔绍山,陆洪光,王书平,高兴华,陈洪铎. 皮肤病患者的心理健康状况及其影响因素[J]. 中华皮肤科杂志, 2008, 41(11): 758-.
[14]	朱国兴, 陆春, 赖维, 冯佩英, 顾有守. 大剂量静脉注射免疫球蛋白治疗25例重症皮肤病的临床分析[J]. 中华皮肤科杂志, 2006, 39(1): 41-43.
[15]	徐薇, 赵俊英, 赵绘, 顾菲, 黄笑鸣. 毛囊闭锁性三联征一例及家系分析[J]. 中华皮肤科杂志, 2005, 38(3): 157-159.

支付意愿在测量皮肤疾病负担中的意义与应用

Application and significance of willingness-to-pay in measuring the burden of skin diseases

PDF

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献 19

相关文章 15

Metrics

本文评价

推荐阅读 10